File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Adipose tissue and the metabolic syndrome: Focusing on adiponectin and several novel adipokines
  • Basic View
  • Metadata View
  • XML View
TitleAdipose tissue and the metabolic syndrome: Focusing on adiponectin and several novel adipokines
 
AuthorsTso, AWK1
Xu, A1
Chow, WS1
Lam, KSL1
 
KeywordsAdipocyte fatty acid-binding protein
Adipokines
Adiponectin
Insulin resistance
Lipocalin-2
Retinol-binding protein 4
The Metabolic syndrome
 
Issue Date2008
 
PublisherFuture Medicine Ltd. The Journal's web site is located at http://www.futuremedicine.com/loi/bmm
 
CitationBiomarkers In Medicine, 2008, v. 2 n. 3, p. 239-252 [How to Cite?]
DOI: http://dx.doi.org/10.2217/17520363.2.3.239
 
AbstractThe metabolic syndrome represents a cluster of metabolic risk factors that predispose an individual to an increased risk for Type 2 diabetes, cardiovascular diseases and their associated morbidity and mortality. Visceral obesity is thought to be a major culprit. Adipokines secreted from the adipose tissue are now believed to be key factors mediating the metabolic and inflammatory effects of obesity. In this review, we shall examine the evidence suggesting that several novel adipokines, adiponectin, adipocyte fatty acid-binding protein, retinol-binding protein-4 and lipocalin-2, may hold promise as important clinical biomarkers to identify individuals at risk for the metabolic syndrome and related comorbidities. © 2008 Future Medicine Ltd.
 
ISSN1752-0363
2012 Impact Factor: 3.217
2012 SCImago Journal Rankings: 0.677
 
DOIhttp://dx.doi.org/10.2217/17520363.2.3.239
 
ISI Accession Number IDWOS:000258921400009
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorTso, AWK
 
dc.contributor.authorXu, A
 
dc.contributor.authorChow, WS
 
dc.contributor.authorLam, KSL
 
dc.date.accessioned2010-09-06T07:33:09Z
 
dc.date.available2010-09-06T07:33:09Z
 
dc.date.issued2008
 
dc.description.abstractThe metabolic syndrome represents a cluster of metabolic risk factors that predispose an individual to an increased risk for Type 2 diabetes, cardiovascular diseases and their associated morbidity and mortality. Visceral obesity is thought to be a major culprit. Adipokines secreted from the adipose tissue are now believed to be key factors mediating the metabolic and inflammatory effects of obesity. In this review, we shall examine the evidence suggesting that several novel adipokines, adiponectin, adipocyte fatty acid-binding protein, retinol-binding protein-4 and lipocalin-2, may hold promise as important clinical biomarkers to identify individuals at risk for the metabolic syndrome and related comorbidities. © 2008 Future Medicine Ltd.
 
dc.description.natureLink_to_subscribed_fulltext
 
dc.identifier.citationBiomarkers In Medicine, 2008, v. 2 n. 3, p. 239-252 [How to Cite?]
DOI: http://dx.doi.org/10.2217/17520363.2.3.239
 
dc.identifier.doihttp://dx.doi.org/10.2217/17520363.2.3.239
 
dc.identifier.epage252
 
dc.identifier.hkuros145457
 
dc.identifier.isiWOS:000258921400009
 
dc.identifier.issn1752-0363
2012 Impact Factor: 3.217
2012 SCImago Journal Rankings: 0.677
 
dc.identifier.issue3
 
dc.identifier.openurl
 
dc.identifier.scopuseid_2-s2.0-48249114800
 
dc.identifier.spage239
 
dc.identifier.urihttp://hdl.handle.net/10722/77553
 
dc.identifier.volume2
 
dc.languageeng
 
dc.publisherFuture Medicine Ltd. The Journal's web site is located at http://www.futuremedicine.com/loi/bmm
 
dc.publisher.placeUnited Kingdom
 
dc.relation.ispartofBiomarkers in Medicine
 
dc.relation.referencesReferences in Scopus
 
dc.subjectAdipocyte fatty acid-binding protein
 
dc.subjectAdipokines
 
dc.subjectAdiponectin
 
dc.subjectInsulin resistance
 
dc.subjectLipocalin-2
 
dc.subjectRetinol-binding protein 4
 
dc.subjectThe Metabolic syndrome
 
dc.titleAdipose tissue and the metabolic syndrome: Focusing on adiponectin and several novel adipokines
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Tso, AWK</contributor.author>
<contributor.author>Xu, A</contributor.author>
<contributor.author>Chow, WS</contributor.author>
<contributor.author>Lam, KSL</contributor.author>
<date.accessioned>2010-09-06T07:33:09Z</date.accessioned>
<date.available>2010-09-06T07:33:09Z</date.available>
<date.issued>2008</date.issued>
<identifier.citation>Biomarkers In Medicine, 2008, v. 2 n. 3, p. 239-252</identifier.citation>
<identifier.issn>1752-0363</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/77553</identifier.uri>
<description.abstract>The metabolic syndrome represents a cluster of metabolic risk factors that predispose an individual to an increased risk for Type 2 diabetes, cardiovascular diseases and their associated morbidity and mortality. Visceral obesity is thought to be a major culprit. Adipokines secreted from the adipose tissue are now believed to be key factors mediating the metabolic and inflammatory effects of obesity. In this review, we shall examine the evidence suggesting that several novel adipokines, adiponectin, adipocyte fatty acid-binding protein, retinol-binding protein-4 and lipocalin-2, may hold promise as important clinical biomarkers to identify individuals at risk for the metabolic syndrome and related comorbidities. &#169; 2008 Future Medicine Ltd.</description.abstract>
<language>eng</language>
<publisher>Future Medicine Ltd. The Journal&apos;s web site is located at http://www.futuremedicine.com/loi/bmm</publisher>
<relation.ispartof>Biomarkers in Medicine</relation.ispartof>
<subject>Adipocyte fatty acid-binding protein</subject>
<subject>Adipokines</subject>
<subject>Adiponectin</subject>
<subject>Insulin resistance</subject>
<subject>Lipocalin-2</subject>
<subject>Retinol-binding protein 4</subject>
<subject>The Metabolic syndrome</subject>
<title>Adipose tissue and the metabolic syndrome: Focusing on adiponectin and several novel adipokines</title>
<type>Article</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=1752-0363&amp;volume=2&amp;spage=239&amp;epage=52&amp;date=2008&amp;atitle=Adipose+tissue+and+the+metabolic+syndrome:+focusing+on+adiponectin+and+several+novel+adipokines</identifier.openurl>
<description.nature>Link_to_subscribed_fulltext</description.nature>
<identifier.doi>10.2217/17520363.2.3.239</identifier.doi>
<identifier.scopus>eid_2-s2.0-48249114800</identifier.scopus>
<identifier.hkuros>145457</identifier.hkuros>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-48249114800&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>2</identifier.volume>
<identifier.issue>3</identifier.issue>
<identifier.spage>239</identifier.spage>
<identifier.epage>252</identifier.epage>
<identifier.isi>WOS:000258921400009</identifier.isi>
<publisher.place>United Kingdom</publisher.place>
</item>
Author Affiliations
  1. The University of Hong Kong